Antiviral T cells safe and effective for treating debilitating complication common after stem cell transplants

(University of Texas M. D. Anderson Cancer Center) A Phase II trial at MD Anderson tound that BK virus (BKV)-specific T cells from healthy donors were safe and effective as an off-the-shelf therapy for BKV-associated hemorrhagic cystitis (BKV-HC), a painful complication common after allogeneic stem cell transplants for patients with leukemia or lymphoma.